Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study

MLA

Ikeda, Kenji, et al. “Interferon Decreases Hepatocellular Carcinogenesis in Patients with Cirrhosis Caused by the Hepatitis B Virus: A Pilot Study.” Cancer, vol. 82, no. 5, Mar. 1998, p. 827. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.20409994&authtype=sso&custid=ns315887.

APA

Ikeda, K., Saitoh, S., Suzuki, Y., Kobayashi, M., Tsubota, A., Fukuda, M., Koida, I., Arase, Y., Chayama, K., Murashima, N., & Kumada, H. (1998, March 1). Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study. Cancer, 82(5), 827.

Chicago

Ikeda, Kenji, Satoshi Saitoh, Yoshiyuki Suzuki, Masahiro Kobayashi, Akihito Tsubota, Mizuho Fukuda, Isao Koida, et al. 1998. “Interferon Decreases Hepatocellular Carcinogenesis in Patients with Cirrhosis Caused by the Hepatitis B Virus: A Pilot Study.” Cancer, March 1. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.20409994&authtype=sso&custid=ns315887.